Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Current Assets (2016 - 2025)

Historic Current Assets for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to $494.8 million.

  • Rhythm Pharmaceuticals' Current Assets rose 4538.42% to $494.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $494.8 million, marking a year-over-year increase of 4538.42%. This contributed to the annual value of $374.2 million for FY2024, which is 2138.79% up from last year.
  • Per Rhythm Pharmaceuticals' latest filing, its Current Assets stood at $494.8 million for Q3 2025, which was up 4538.42% from $360.7 million recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Current Assets registered a high of $494.8 million during Q3 2025, and its lowest value of $235.8 million during Q1 2024.
  • Its 5-year average for Current Assets is $338.2 million, with a median of $340.3 million in 2024.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 5989.21% in 2021, then plummeted by 3850.33% in 2022.
  • Rhythm Pharmaceuticals' Current Assets (Quarter) stood at $308.4 million in 2021, then rose by 14.87% to $354.2 million in 2022, then decreased by 12.98% to $308.3 million in 2023, then grew by 21.39% to $374.2 million in 2024, then skyrocketed by 32.23% to $494.8 million in 2025.
  • Its Current Assets was $494.8 million in Q3 2025, compared to $360.7 million in Q2 2025 and $369.3 million in Q1 2025.